Pure Red Cell Aplasia secondary to Erythropoietin Therapy.
Pure red cell aplasia
erythropoietin
Journal
Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853
Informations de publication
Date de publication:
17 Jul 2024
17 Jul 2024
Historique:
received:
09
04
2024
accepted:
12
07
2024
medline:
20
7
2024
pubmed:
20
7
2024
entrez:
19
7
2024
Statut:
aheadofprint
Résumé
We report a case series of two chronic kidney disease patients (CKD) who developed erythropoietin-induced pure red cell aplasia following a change in erythropoietin preparation. Both patients responded well to immunosuppressive treatments, but unfortunately developed severe infections as a result of being immunosuppressed.
Identifiants
pubmed: 39029801
pii: S1470-2118(24)05414-9
doi: 10.1016/j.clinme.2024.100229
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100229Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None